For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Nutrien Ltd’s stock clocked out at $60.44, down -0.33% from its previous closing price of $60.64. In other words, the price has decreased by -$0.33 from its previous closing price. On the day, 1.91 million shares were traded. NTR stock price reached its highest trading level at $60.9 during the session, while it also had its lowest trading level at $59.93.
Ratios:
To gain a deeper understanding of NTR’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 21.24 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 16.37. For the most recent quarter (mrq), Quick Ratio is recorded 0.85 and its Current Ratio is at 1.33. In the meantime, Its Debt-to-Equity ratio is 0.54 whereas as Long-Term Debt/Eq ratio is at 0.43.
On July 11, 2025, Jefferies Downgraded its rating to Hold which previously was Buy but kept the price unchanged to $66.
Raymond James Downgraded its Outperform to Mkt Perform on June 17, 2025, while the target price for the stock was maintained at $68.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NTR now has a Market Capitalization of 29366831104 and an Enterprise Value of 41648832512. As of this moment, Nutrien’s Price-to-Earnings (P/E) ratio for their current fiscal year is 21.65, and their Forward P/E ratio for the next fiscal year is 13.17. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.81. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.13 while its Price-to-Book (P/B) ratio in mrq is 1.17. Its current Enterprise Value per Revenue stands at 1.665 whereas that against EBITDA is 9.019.
Stock Price History:
The Beta on a monthly basis for NTR is 0.85, which has changed by 0.23271465 over the last 52 weeks, in comparison to a change of 0.16845357 over the same period for the S&P500. Over the past 52 weeks, NTR has reached a high of $65.08, while it has fallen to a 52-week low of $43.69. The 50-Day Moving Average of the stock is 4.76%, while the 200-Day Moving Average is calculated to be 9.73%.
Shares Statistics:
It appears that NTR traded 2.44M shares on average per day over the past three months and 3173480 shares per day over the past ten days. A total of 487.49M shares are outstanding, with a floating share count of 487.14M. Insiders hold about 0.07% of the company’s shares, while institutions hold 76.09% stake in the company. Shares short for NTR as of 1757894400 were 5259540 with a Short Ratio of 2.15, compared to 1755216000 on 3430329. Therefore, it implies a Short% of Shares Outstanding of 5259540 and a Short% of Float of 1.08.
Dividends & Splits
With its trailing 12-month dividend rate of 2.17, NTR has a forward annual dividend rate of 2.18. Against a Trailing Annual Dividend Yield of 0.035784964. The stock’s 5-year Average Dividend Yield is 3.32.
Earnings Estimates
Nutrien Ltd (NTR) is currently under the scrutiny of 17.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is $0.88, with high estimates of $1.23 and low estimates of $0.72.
Analysts are recommending an EPS of between $5.15 and $4.13 for the fiscal current year, implying an average EPS of $4.55. EPS for the following year is $4.49, with 23.0 analysts recommending between $5.27 and $3.18.
Revenue Estimates
In. The current quarter, 8 analysts expect revenue to total $5.59B. It ranges from a high estimate of $5.89B to a low estimate of $5.39B. As of. The current estimate, Nutrien Ltd’s year-ago sales were $5.08BFor the next quarter, 8 analysts are estimating revenue of $5.27B. There is a high estimate of $5.41B for the next quarter, whereas the lowest estimate is $5.16B.
A total of 16 analysts have provided revenue estimates for NTR’s current fiscal year. The highest revenue estimate was $27.26B, while the lowest revenue estimate was $25.68B, resulting in an average revenue estimate of $26.36B. In the same quarter a year ago, actual revenue was $25.02BBased on 16 analysts’ estimates, the company’s revenue will be $26.67B in the next fiscal year. The high estimate is $28.28B and the low estimate is $25.75B.
